Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulation of microRNAs through Lifestyle Changes in Alzheimer's Disease. | Nutrients | 2023 | 37686720 | PubTator, text mining | PubMed |
| Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice. | Cancers (Basel) | 2023 | 37686621 | PubTator, text mining | PubMed |
| Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37686496 | PubTator, text mining | PubMed |
| Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks. | Int J Mol Sci | 2023 | 37686426 | PubTator, text mining | PubMed |
| Common miRNAs of Osteoporosis and Fibromyalgia: A Review. | Int J Mol Sci | 2023 | 37686318 | PubTator, text mining | PubMed |
| Can Genetic Markers Predict the Sporadic Form of Alzheimer's Disease? An Updated Review on Genetic Peripheral Markers. | Int J Mol Sci | 2023 | 37686283 | PubTator, text mining | PubMed |
| Research Advances in the Role of the Tropomyosin Family in Cancer. | Int J Mol Sci | 2023 | 37686101 | PubTator, text mining | PubMed |
| MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications. | Oxid Med Cell Longev | 2023 | 37675243 | PubTator, text mining | PubMed |
| Molecular immune monitoring in kidney transplant rejection: a state-of-the-art review. | Front Immunol | 2023 | 37675106 | PubTator, text mining | PubMed |
| Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. | World J Gastroenterol | 2023 | 37664153 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in Development of Endometrial Cancer: A Literature Review. | J Reprod Infertil | 2023 | 37663424 | PubTator, text mining | PubMed |
| Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37663266 | PubTator, text mining | PubMed |
| Identification of molecular subtypes and immune infiltration in endometriosis: a novel bioinformatics analysis and In vitro validation. | Front Immunol | 2023 | 37662927 | PubTator, text mining | PubMed |
| Differentially expressed non-coding RNAs and their regulatory networks in liver cancer. | Heliyon | 2023 | 37662778 | PubTator, text mining | PubMed |
| Identification of immune-related biomarkers co-occurring in acute ischemic stroke and acute myocardial infarction. | Front Neurol | 2023 | 37662030 | PubTator, text mining | PubMed |
| Enterovirus D68 infection upregulates SOCS3 expression to inhibit JAK-STAT3 signaling and antagonize the innate interferon response of the host. | Virol Sin | 2023 | 37657555 | PubTator, text mining | PubMed |
| Research Progress and Molecular Mechanisms of Endothelial Cells Inflammation in Vascular-Related Diseases. | J Inflamm Res | 2023 | 37641702 | PubTator, text mining | PubMed |
| Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles. | Front Oncol | 2023 | 37637043 | PubTator, text mining | PubMed |
MiRNA-mRNA integrative analysis reveals epigenetically regulated and prognostic miR-103a with a role in migration and invasion of carboplatin-resistant ovarian cancer cells that acquired mesenchymal-like phenotype. | Biomed Pharmacother | 2023 | 37634476 | PubTator, text mining | PubMed |
| Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics. | Pharmaceutics | 2023 | 37631335 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=13